Kiora Pharmaceuticals, Inc.
KPRX · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $27 | -$2,152 | -$2,193 | -$4,224 |
| Dep. & Amort. | $38 | $3 | $0 | $6 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $263 | $149 | $160 |
| Change in WC | $87 | -$2,073 | -$931 | $2,103 |
| Other Non-Cash | -$1,425 | $155 | $271 | -$298 |
| Operating Cash Flow | -$1,273 | -$3,803 | -$2,704 | -$2,252 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$32 | $0 | $45 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$4,557 | -$3,619 | -$6,539 |
| Inv. Sales/Matur. | $5,741 | $5,253 | $6,292 | $6,976 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $5,741 | $664 | $2,673 | $483 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $265 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | $0 | $265 | $0 | $0 |
| Forex Effect | $13 | $132 | $10 | -$75 |
| Net Chg. in Cash | $4,481 | -$2,742 | -$21 | -$1,845 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $1,028 | $3,775 | $3,796 | $5,642 |
| End Cash | $5,509 | $1,033 | $3,775 | $3,796 |
| Free Cash Flow | -$1,274 | -$3,836 | -$2,704 | -$2,207 |